Related Experiment Videos
Sepiapterin reductase in cultured human cells
1Department of Genetics, Faculty of Biological Sciences, University of Valencia, Burjasot, Spain.
Biochemical and Biophysical Research Communications
|November 13, 1987
Summary
Sepiapterin reductase activity was analyzed in human amniotic fibroblasts and blood cells. Results indicate the same enzyme catalyzes tetrahydrobiopterin synthesis in both cell types.
Area of Science:
- Biochemistry
- Enzymology
- Cell Biology
Background:
- Tetrahydrobiopterin (BH4) is a crucial cofactor for aromatic amino acid hydroxylases.
- Sepiapterin reductase (SR) is a key enzyme in the BH4 synthesis pathway.
- Understanding SR activity in different human cell types is important for metabolic research.
Purpose of the Study:
- To compare the kinetic properties and inhibition patterns of sepiapterin reductase in cultured human amniotic fibroblasts and mononuclear blood cells.
- To determine if the same SR enzyme is responsible for BH4 synthesis in these distinct cell types.
Main Methods:
- Enzyme assays were performed on cultured human amniotic fibroblasts and mononuclear blood cells.
- Michaelis constants (Km) for sepiapterin and NADPH were determined.
- Inhibition kinetics using N-acetylserotonin were analyzed.
Main Results:
- Michaelis constants for sepiapterin and NADPH were similar in both cell types.
- The concentration of N-acetylserotonin causing 50% inhibition was comparable between fibroblasts and blood cells.
- Kinetic parameters and inhibition profiles suggest a common sepiapterin reductase enzyme.
Conclusions:
- The sepiapterin reductase enzyme in human amniotic fibroblasts and mononuclear blood cells exhibits similar kinetic properties and inhibition responses.
- These findings strongly suggest that the same enzyme is responsible for tetrahydrobiopterin synthesis in both cell types when cultured.
- This implies conserved enzymatic function across different human cell lineages in vitro.